National Pharmaceuticals Pricing Authority
-
{
- All
- News
-
Centre Revises Coronary Stent Prices From April 2026: Here's How Much It Should Cost You Now
National Pharmaceutical Pricing Authority revises stent prices, DES capped at Rs 39,186, BMS at Rs 10,762, effective April 2026.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Prices of 98 Drugs Not Fixed Due to Lack of Information
The government has not fixed the ceiling price of 98 drugs used for treating various diseases such as tuberculosis, cardiac conditions and infections due to non-availability of information.
-
Centre Revises Coronary Stent Prices From April 2026: Here's How Much It Should Cost You Now
National Pharmaceutical Pricing Authority revises stent prices, DES capped at Rs 39,186, BMS at Rs 10,762, effective April 2026.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Remdesivir Prices Cut On Government Intervention: Industry Body
To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government's intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
-
Fortis Hospital Charged Adya's Parents 1,208 Per Cent More For Syringes: NPPA
The Fortis Memorial hospital in Gurgaon charged 1,208 per cent more than procurement price for much of the medical equipment, including disposable syringes, to the parents of seven-year-old dengue patient Adya who had died at the hospital despite undergoing treatment for two weeks.
-
Fortis Dengue Case: Drug Pricing Body Seeks Bill Copies From Hospital
The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
Prices of Cancer and Diabetes Drugs Are Slashed Down by 86%
In a series of tweets, the National Pharmaceutical Pricing Authority or NPPA on Monday announced just how the authority has come to the rescue of all those spending thousands.
-
Prices of 98 Drugs Not Fixed Due to Lack of Information
The government has not fixed the ceiling price of 98 drugs used for treating various diseases such as tuberculosis, cardiac conditions and infections due to non-availability of information.
